Journals / Afyon Kocatepe Üniversitesi Uluslararası Mühendislik Teknolojileri ve Uygulamalı Bilimler Dergisi / 2023 / Cilt: 6 Sayı: 1

Biosensor Studies For The Diagnosis Of Pancreas Cancer In Early Stages

Pankreas Kanserinin Erken Evrelerde Teşhisi için Yapılan Biyosensör Çalışmaları

Pages
81–94
Publication Date
2023-06-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, biosensor studies for the detection of biomarkers such as miRNA and protein, which are revealed in the presence of pancreatic cancer, are included.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pancreatic cancer is a type of cancer with a poor prognosis and high mortality rate.
📊
Key Findings & Data:The 5-year survival rate in diagnosed patients is 6% on average.
💡
Conclusion & Impact:In this study, biosensor studies for the detection of biomarkers such as miRNA and protein, which are revealed in the presence of pancreatic cancer, are included.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Pankreas kanseri · Pankreas Kanseri Belirtileri · Biyobelirteçler

Abstract

Pancreatic cancer is a type of cancer with a poor prognosis and high mortality rate. Pancreatic cancer, which is an aggressive type of cancer, is very difficult to detect early and is usually diagnosed in later stages. The 5-year survival rate in diagnosed patients is 6% on average. Therefore, early detection of pancreatic cancer has an important role in increasing the survival rate and reducing mortality rates as a result of early intervention. Imaging techniques such as biopsy, ultrasound, and magnetic resonance are used as traditional methods in the diagnosis of pancreatic cancer, but these techniques are expensive, take a lot of time and need to be performed and analyzed by experts in the field in order to obtain accurate and precise results. For this reason, biosensors, which are more accessible, inexpensive, can be used by everyone, and have a high probability of giving accurate results, have been suggested to be used in the diagnosis of pancreatic cancer. In this study, biosensor studies for the detection of biomarkers such as miRNA and protein, which are revealed in the presence of pancreatic cancer, are included.

Özet

Pankreas kanseri, kötü prognoza ve yüksek ölüm oranına sahip bir kanser türüdür. Agresif bir kanser türü olan pankreas kanserinin erken tespit edilmesi oldukça zordur ve genellikle ileriki evrelerde kesin olarak teşhis koyulmaktadır. Teşhis konulan hastalarda 5 yıllık sağkalım oranı ortalama % 6’dır. Bu yüzden, pankreas kanserinin erken teşhis edilmesi, erken müdahale sonucu sağkalım oranını arttırmada ve ölüm oranlarını azaltmada önemli bir role sahiptir. Pankreas kanserinin teşhis edilmesinde geleneksel yöntemler olarak biyopsi, ultrason, manyetik rezonans gibi görüntüleme teknikleri kullanılır ancak bu teknikler pahalı, çok zaman almakta ve doğru, kesin sonuçlar alabilmek için alanında uzman kişiler tarafından yapılması ve analiz edilmesi gerekmektedir. Bu nedenle daha kolay ulaşılabilen, ucuz, herkes tarafından kullanılabilme özelliğine sahip ve doğru sonuç verme olasılığı yüksek araçlar olan biyosensörler, pankreas kanserinin teşhisinde kullanılması önerilmiştir. Bu çalışmada pankreas kanserinin varlığında açığa çıkan miRNA, protein gibi biyobelirteçlerin tespitine yönelik biyosensör çalışmalarına yer verilmiştir.

🔖

Cite This Article

ÖZBEK, Z., GÜR, N. (2023). Biosensor Studies For The Diagnosis Of Pancreas Cancer In Early Stages. Afyon Kocatepe Üniversitesi Uluslararası Mühendislik Teknolojileri ve Uygulamalı Bilimler Dergisi, Cilt: 6 Sayı: 1, 81–94. https://ajindex.com/articles/945309

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Abe, K., Kitago, M., Kitagawa, Y. & Hirasawa, A.2021. Hereditary pancreatic cancer. Int. J. Clin. Oncol. 26, 1784–1792.
  2. Ahmadi, Y. & Kim, K. H. 2020. Functionalization and customization of polyurethanes for biosensing applications: A state-of-the-art review. TrAC Trends Anal. Chem. 126, 115881. Ambai, V. T., Singh, V., Boorman, D. W. & Neufeld, N. J. 2021. Celiac plexus neurolysis for abdominal cancers: going beyond pancreatic cancer pain. PAIN Reports. 6, e930. Ambartsumyan, O., Gribanyov, D., Kukushkin, V., Kopylov, A. & Zavyalova, E. 2020. SERS Based Biosensors for Virus Determination with Oligonucleotides as Recognition Elements. Int. J. Mol. Sci. 21, 3373. Anik, Ü. & Timur, S. 2016. Towards the electrochemical diagnosis of cancer: nanomaterialbased immunosensors and cytosensors. RSC Adv. 6, 111831–111841.
  3. Aydın B., E., Aydın, M. & Kemal Sezgintürk, M. 2019. Biosensors and the evaluation of food contaminant biosensors in terms of their performance criteria. Inter.Jour. of Envi. Analyt. Chem. 100, 602–622.
  4. Blum, R. & Kloog, Y. 2014. Metabolism addiction in pancreatic cancer. Cell Death Dis. 52 5, e1065–e1065. Cao, H., Fang, X., Li, H., Li, H. & Kong, J. 2017.Ultrasensitive detection of mucin 1 biomarker by immuno-loop-mediated isothermal amplification. Talanta. 164, 588–592.
  5. Cao, X., Ye, Y. & Liu, S. 2011. Gold nanoparticle-based signal amplification for biosensing. Anal. Biochem. 417, 1–16.
  6. Cesewski, E. & Johnson, B. N. 2020. Electrochemical biosensors for pathogen detection. Biosens. Bioelectron. 159, 112214. Chen, Ss. C., Chen, K. T. & Jou, A. F. J. 2021. Polydopamine-gold composite-based electrochemical biosensor using dual-amplification strategy for detecting pancreatic cancerassociated microRNA. Biosens. Bioelectron. 173, 112815. Conroy, T. et al. 2016. Current standards and new innovative approaches for treatment of pancreatic cancer. Eur. J. Cancer. 57, 10–22.
  7. Cornman-Homonoff, J., Holzwanger, D. J., Lee, K. S., Madoff, D. C. & Li, D. 2017. Palliative Care Interventions in the Cancer Patient: Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal Pain. Semin. Intervent. Radiol. 34, 376. D’amora, M. et al. 2019. Carbon Nano-Onions as Non-Cytotoxic Carriers for Cellular Uptake of Glycopeptides and Proteins. Nanomater. Vol. 9, Page 1069 9, 1069. Dobosz, Ł. et al. 2016. Pain in pancreatic cancer: review of medical and surgical remedies. ANZ J. Surg. 86, 756–761. Dutta K. S. et al. 2012. Serum HSP70: a novel biomarker for ear